Matrix metalloproteinase-12, an indicator potentially contributing to the differential diagnosis and activity assessment of retroperitoneal fibrosis
The positive rate of MMP-12 in the GCs of pathological tissues is a potential marker that contributes to the differential diagnosis of RPF and might be associated with the degree of fibrosis, although MMP-12 in the peripheral blood was not very helpful for disease diagnosis and monitoring of treatment effects. MMP-12 had the potential to become an indicator for the differential diagnosis RPF and monitoring the disease process.
Authors
- Hui Gao (ORCID: https://orcid.org/0000-0002-3303-9767)
- Jinxia Zhao (ORCID: https://orcid.org/0000-0002-8225-0921)
- Jun Lian Gao (ORCID: https://orcid.org/0000-0002-2372-4445)
- Xiaoying Zhang (ORCID: https://orcid.org/0000-0002-9541-7479)
- Tong Zheng (ORCID: https://orcid.org/0009-0005-1488-2846)
- Shibo Liu (ORCID: https://orcid.org/0000-0001-9482-7014)
Institutions
- Peking University (CN)
- Peking University International Hospital (CN)
- Peking University Third Hospital (CN)
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2024-10-11
- DOI
- https://doi.org/10.55563/clinexprheumatol/ys972g
- Primary Topic
- IgG4-Related and Inflammatory Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00